Top 10 Medical Stocks To Watch For 2019


The typical business model of an engineering consultancy firm like Exponent, Inc. (NASDAQ:EXPO) is simple yet attractive. These firms are pure manpower-driven businesses that cater to a vast array of industries, work mostly on medium-to-long-term contracts, have negligible direct costs other than manpower, and have strong foreseeability of revenues. Also, the low capital expenditure associated with such businesses makes them very attractive for leveraged buyouts.

EXPO also has all these characteristics and the company has been growing extremely well over the past decade. Our assessment of the company’s business and our financial evaluation indicate that it is a solid script with a bright future ahead. EXPO has been consistently delivering returns to its investors since over a decade and is expected to continue doing so for the next few years.

Company Overview


EXPO is one of the top American players within the engineering and scientific consulting services sector. It operates through two main business segments: engineering & other scientific consulting and environmental & health-related consulting. The former includes activities such as civil engineering, construction consulting, biomechanics, biomedical engineering, and so on and accounts for about 79% of the company’s total revenues. The environment and health segment provides services in the fields of food safety, health risk analysis, environmental, and other related regulations. The company generates most of its revenues from the US and has a workforce of 1,075 employees including engineers, scientists, physicians, regulatory experts, and so on. It is headquartered in Menlo Park, CA.

Top 10 Medical Stocks To Watch For 2019: First Financial Corporation Indiana(THFF)


Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on First Financial Co. Indiana (THFF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Financial (THFF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    BidaskClub upgraded shares of First Financial (NASDAQ:THFF) from a buy rating to a strong-buy rating in a research report released on Thursday.

    Other equities analysts also recently issued research reports about the company. Zacks Investment Research raised First Financial from a sell rating to a buy rating and set a $51.00 price objective on the stock in a research report on Thursday, June 28th. ValuEngine raised First Financial from a sell rating to a hold rating in a research report on Tuesday, June 26th.

Top 10 Medical Stocks To Watch For 2019: EV Energy Partners, L.P.(EVEP)


Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%


    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top 10 Medical Stocks To Watch For 2019: Discovery Communications, Inc.(DISCB)

Advisors’ Opinion:

  • [By Billy Duberstein]

    Discovery, Inc. (NASDAQ:DISCA) (NASDAQ:DISCB) (NASDAQ:DISCK) has traded very cheaply over the past few years. As more and more U.S. consumers “cut the cord” on the traditional cable bundle, Discovery’s channels (which now include all Scripps Networks Interactive channels) have seen their subscriber counts decline. That, combined with the high debt load incurred for the company’s 2017 acquisition of Scripps Networks Interactive, sent investors running for the hills last year. In 2017, the company’s three share classes dropped from roughly 10% to roughly 21%.

  • [By Billy Duberstein]

    You might think Discovery Inc.’s (NASDAQ:DISCA) (NASDAQ:DISCK) (NASDAQ:DISCB) stations primarily feature nature videos and celebrity cooks, but did you know it’s actually becoming a player on the international sports scene? While known for its namesake Discovery Channel and documentary brands such as The Learning Channel, HGTV, and the Food Network, Discovery has actually been in the sports business since 2012, when it first acquired a minority stake in European sports channel Eurosport. Discovery was apparently pleased enough with the channel’s progress to buy 100% of Eurosport in July 2015, and that year, Eurosport won the exclusive rights to broadcast the Olympics in Europe from 2018-2022.

  • [By Max Byerly]

    Discovery (NASDAQ:DISCB) announced its quarterly earnings results on Tuesday. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.13, Morningstar.com reports. Discovery had a negative net margin of 7.40% and a positive return on equity of 19.34%. The company had revenue of $2.31 billion for the quarter.

Top 10 Medical Stocks To Watch For 2019: Cheniere Energy Partners LP Holdings, LLC(CQH)

Advisors’ Opinion:

  • [By Paul Ausick]

    Cheniere Energy Inc. (NYSEAMERICAN: LNG) announced Thursday morning that it is acquiring the approximately 8.1% of subsidiary Cheniere Energy Partners Holdings LLC (NYSEAMERICAN: CQH) that it does not already own in an all-stock deal valued at $28.24 per share of Cheniere Partners Holdings.

  • [By Stephan Byrd]

    Gabelli Funds LLC acquired a new stake in shares of Cheniere Energy Partners LP Holdings LLC (NYSEAMERICAN:CQH) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 18,263 shares of the energy company’s stock, valued at approximately $574,000.

  • [By Logan Wallace]

    Shares of Cheniere Energy Partners (NYSEAMERICAN:CQH) have received an average rating of “Hold” from the seven ratings firms that are currently covering the company, Marketbeat reports. Five analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $30.88.

  • [By Tyler Crowe]

    Also, after grappling with the issue for several quarters, management was finally able to finalize a deal to acquire the remaining shares outstanding in Cheniere Energy Partners Holdings (NYSEMKT:CQH). Management made an initial offer to acquire the subsidiary holding company back in 2016 as a way to simplify its corporate structure, but it was hung up in a conflicts committee with the board for some time. The new deal is now finalized and set to close this quarter.

  • [By Reuben Gregg Brewer]

    I wouldn’t personally buy Cheniere Energy — it has a complex corporate structure that includes not just Cheniere Energy Partners, L.P. but also Cheniere Energy Partners LP Holdings LLC (NYSE: CQH), where the only asset is an ownership stake in Cheniere Energy Partners, L.P. Cheniere Energy is attempting to resolve this issue by acquiring Cheniere Energy Partners LP Holdings. Until that process is complete, however, that’s just too much corporate complexity for my taste.

  • [By Paul Ausick]

    Liquefied natural gas (LNG) producer Cheniere Energy Inc. (NYSEAMERICAN: LNG) has agreed to acquire all publicly traded shares that it does not already own in Cheniere Energy Partners LP Holdings LLC (NYSEAMERICAN: CQH) for $30.93 per share in Cheniere Energy stock. The transaction is expected to be tax-free to Cheniere Holdings shareholders. The proposed acquisition was first announced on May 17.

Top 10 Medical Stocks To Watch For 2019: Timberland Bancorp Inc.(TSBK)


Advisors’ Opinion:

  • [By Ethan Ryder]

    Press coverage about Timberland Bancorp (NASDAQ:TSBK) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. Accern ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Timberland Bancorp earned a daily sentiment score of 0.01 on Accern’s scale. Accern also gave media coverage about the savings and loans company an impact score of 46.0053181885204 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Shane Hupp]

    Timberland Bancorp, Inc. (NASDAQ:TSBK) declared a None dividend on Tuesday, April 24th, Zacks reports. Investors of record on Friday, May 11th will be paid a dividend of 0.23 per share by the savings and loans company on Friday, May 25th. This represents a dividend yield of 1.61%. The ex-dividend date is Thursday, May 10th.

Top 10 Medical Stocks To Watch For 2019: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 4.2% during the second quarter, Holdings Channel reports. The institutional investor owned 15,467 shares of the biopharmaceutical company’s stock after buying an additional 630 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Regeneron Pharmaceuticals were worth $5,336,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Max Byerly]

    Gulf International Bank UK Ltd reduced its position in Regeneron (NASDAQ:REGN) by 1.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 24,488 shares of the biopharmaceutical company’s stock after selling 297 shares during the period. Gulf International Bank UK Ltd’s holdings in Regeneron were worth $8,432,000 as of its most recent filing with the SEC.

  • [By Cory Renauer]

    Sanofi (NYSE:SNY) and Regeneron (NASDAQ:REGN) launched a cholesterol-lowering treatment in 2015 that could be a big problem for bempedoic acid, even if its safety profile remains intact. Praluent is a remarkable drug that can turn stubborn liver cells into cholesterol sponges, but at an initial list price of around $14,000 per year, its launch was a huge disappointment.

  • [By ]

    In the Lightning Round, Cramer was bullish on The Blackstone Group (BX) , Nvidia  (NVDA) , Amgen (AMGN) , Regeneron Pharmaceuticals (REGN) , Hasbro (HAS) and Waste Management (WM) .

Top 10 Medical Stocks To Watch For 2019: Camden Property Trust(CPT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Barclays upgraded shares of Camden Property Trust (NYSE:CPT) from an equal weight rating to an overweight rating in a research report report published on Monday morning, Marketbeat reports. Barclays currently has $106.00 target price on the real estate investment trust’s stock, up from their previous target price of $87.00.

  • [By Motley Fool Transcribers]

    Camden Property Trust  (NYSE:CPT)Q4 2018 Earnings Conference CallFeb. 01, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Cryptaur (CURRENCY:CPT) traded up 2.6% against the US dollar during the 1-day period ending at 10:00 AM ET on June 14th. Cryptaur has a total market capitalization of $0.00 and $255,998.00 worth of Cryptaur was traded on exchanges in the last 24 hours. Over the last seven days, Cryptaur has traded 2.4% higher against the US dollar. One Cryptaur token can now be purchased for $0.0042 or 0.00000065 BTC on popular cryptocurrency exchanges including HitBTC and LATOKEN.

  • [By Max Byerly]

    Amundi Pioneer Asset Management Inc. lifted its holdings in Camden Property Trust (NYSE:CPT) by 8.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 291,582 shares of the real estate investment trust’s stock after acquiring an additional 21,627 shares during the period. Amundi Pioneer Asset Management Inc. owned approximately 0.31% of Camden Property Trust worth $24,545,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Camden Property Trust (CPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News articles about Camden Property Trust (NYSE:CPT) have trended positive recently, according to Accern. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Camden Property Trust earned a coverage optimism score of 0.29 on Accern’s scale. Accern also assigned media coverage about the real estate investment trust an impact score of 47.1765126263188 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 10 Medical Stocks To Watch For 2019: Hollysys Automation Technologies Ltd.(HOLI)


Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Travis Hoium]

    Shares of Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) fell as much as 31.5% in trading Wednesday, after the company reported fiscal fourth-quarter 2018 results. By the time the market closed, some of those gains had been clawed back but were still down 11.1% for the day. 

  • [By Stephan Byrd]

    Hollysys Automation Technologies (NASDAQ: HOLI) and GrafTech (NYSE:EAF) are both industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

  • [By Stephan Byrd]

    Hollysys Automation Technologies Ltd (NASDAQ:HOLI) has been assigned an average rating of “Hold” from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $21.44.

Top 10 Medical Stocks To Watch For 2019: MFS Charter Income Trust(MCR)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Macro (CURRENCY:MCR) traded flat against the U.S. dollar during the 24 hour period ending at 20:00 PM E.T. on May 30th. During the last seven days, Macro has traded down 6% against the U.S. dollar. Macro has a total market cap of $0.00 and approximately $0.00 worth of Macro was traded on exchanges in the last day. One Macro token can now be bought for about $0.17 or 0.00002339 BTC on popular cryptocurrency exchanges.

  • [By Ethan Ryder]

    Macro (CURRENCY:MCR) traded flat against the dollar during the 24 hour period ending at 12:00 PM E.T. on August 26th. Macro has a market cap of $0.00 and approximately $0.00 worth of Macro was traded on exchanges in the last day. In the last week, Macro has traded flat against the dollar. One Macro token can currently be bought for about $0.17 or 0.00002327 BTC on major exchanges.

Top 10 Medical Stocks To Watch For 2019: Research Frontiers Incorporated(REFR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Research Frontiers, Inc. (NASDAQ:REFR) insider Kevin Douglas acquired 163,044 shares of the stock in a transaction on Tuesday, September 11th. The shares were purchased at an average cost of $0.92 per share, with a total value of $150,000.48. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Research Frontiers (REFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning Staff Reports]

    However, Seven Star’s gains are already on the books. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 70%…

    Penny Stock Current Share Price Last Week’s Gain
    Seven Stars Cloud Group Inc. (Nasdaq: SSC) $4.49 175.13%
    Alliance MMA Inc. (Nasdaq: AMMA) $0.37 121.05%
    India Globalization Capital Inc. (NYSE: IGC) $1.14 74.38%
    Obalon Therapeutics Inc. (Nasdaq: OBLN) $3.23 63.16%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.56 55.76%
    Atlanticus Holdings Corp. (Nasdaq: ATLC) $2.85 43.55%
    Research Frontiers Inc. (Nasdaq: REFR) $1.28 41.37%
    Koss Corp. (Nasdaq: KOSS) $4.08 41.28%
    GLG Life Tech Corp. (TSE: GLG) $0.88 33.90%
    Geron Corp. (Nasdaq: GERN) $4.76 32.40%

    While those gains are already in the book, you don’t have to miss out on the next penny stocks to soar.

  • [By Ethan Ryder]

    Research Frontiers (NASDAQ: REFR) and RPX (NASDAQ:RPXC) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings.

  • [By Shane Hupp]

    News articles about Research Frontiers (NASDAQ:REFR) have trended somewhat positive this week, according to Accern. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Research Frontiers earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave media stories about the technology company an impact score of 46.129953752672 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Leave a Reply

Your email address will not be published.